M.D., Ph.D., Director, Institute for Computational Health Sciences, UCSF
Atul Butte, MD, PhD is the new Director of the new Institute of Computational Health Sciences (ICHS) at the University of California, San Francisco, and a Professor of Pediatrics. Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children's Hospital Boston, then received his PhD from Harvard Medical School and MIT. Dr. Butte has authored nearly 200 publications, with research repeatedly featured in Wired Magazine, the New York Times, and the Wall Street Journal. In 2013, Dr. Butte was recognized by the White House as an Open Science Champion of Change for promoting science through publicly available data. Dr. Butte is also a founder of three investor-backed data-driven companies: Personalis, providing clinical interpretation of whole genome sequences, Carmenta (acquired by Progenity), discovering diagnostics for pregnancy complications, and NuMedii, finding new uses for drugs through open molecular data. Dr. Butte is also the principal investigator of ImmPort, the clinical and molecular data repository for the National Institute of Allergy and Infectious Diseases.
Session: Data-Driven Rx & Dx
The availability of large clinical data and other data types (e.g. toxicology, pharmacogenomics, omics, etc.) combined with the fast-paced evolution of innovative data mining tools allows us to gain new and unprecedented molecular and clinical insights. These data have the potential to impact the world of healthcare in many ways: enabling the identification of new therapeutic targets, finding new uses for existing drugs, allows the identification and characterization of new diagnostic tools, or brings us closer to the understanding of the molecular details of poorly characterized diseases. In this session, we will discuss applications and advancements that build upon large data as applied to both the therapeutics and clinical diagnostics.